Berlex Bonefos Meeting For Breast Cancer Metastases Cancelled
This article was originally published in The Pink Sheet Daily
Executive Summary
It is the second time an FDA advisory committee meeting for Bonefos has been cancelled. The oncologics committee will still meet Dec. 1 to review Ilex/Enzon’s Marqibo and Ilex’ Clolar.